HEAD OF HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR) - ZURICH

Lieu: Switzerland - Glattbrugg/Zurich

Fonction: Pricing and Market Access

Compagnie: Vifor Pharma

Georgia Izzat

International Talent Acquisition Specialist

+41 58 851 83 78

Conditions pour les agences de placement

Votre profil

Are you looking for a new challenge in a specialist pharmaceutical company?  An opportunity has arisen to join our Global Market Access leadership team at our operational headquarters in Glattbrugg. The position of Head of Health Economics and Outcomes Research (HEOR) will have the ability to develop and manage the resourcing plan for HEOR support across all Vifor therapies (balancing FTEs of up to 2 direct reports and location in function of TA focus and archetype focus, outsourcing of implementation, and other solutions).
You will develop and implement the HEOR strategy (including PROs, contribution to interventional and non-interventional data generation, etc) across all of Vifor’s therapies.
 
This Head of Health Economics and Outcomes Research (HEOR) role will have the following responsibilities:  
  • Lead the development of HEOR evidence that supports business strategies and Market Access efforts
  • Development and execution of evidence leveraging Vifor’s disease area expertise, supporting Market Access strategies, engaging decision-makers, influencers, and stakeholders, in order to have the appropriate data (clinical, QoL, economic, societal) to support patient access
  • The role will represent Vifor internally and externally as a trusted partner and credible advisor
  • Develops an effective HEOR team to design and execute strategies that demonstrate product value and support Market Access
  • Works directly with other Market Access teams to meet the needs of patients, payers and policy makers
  • Manages the coordination and collaboration of global, regional and country health economic teams to understand country-specific HEOR needs and opportunities and the respective activities
  • Oversees that HEOR advises Medical Affairs and Clinical teams in the design of health outcomes/interventional and observational trials with health economic and Patient Reported Outcomes (PRO) endpoints in alignment with therapy and product value propositions for optimal impact on access decision-makers, influencers, and stakeholders
  • Leads the development and coordination of company wide health economic tools that are part of the “core value tools” including BIM, CEM, GVD (AMCP & EUNetHTA format)

The knowledge and skills necessary to perform the duties of this position are typically acquired through the following combination of education, experience and knowledge, or the equivalent.

Minimum Requirements:
  • Undergraduate degree in Health or Social Sciences
  • PhD, MSc, or equivalent in Health Economics, Public Health, Mathematics or related field
  • 10 years of experience in health economics and/or outcomes research in pharmaceutical industry
  • Experience in one or more key markets (geographic or disease area markets) would be ideal (including top 5 European and/or the US, as well as ESRD and/or CHF)
  • Language requirement: English plus one other language ideally French, German, or Spanish

We offer you an interesting and challenging opportunity in an international company. As a medium sized specialty Pharmaceutical company we work cross-functionally, with lean structures and an entrepreneurial mind-set. To achieve our goals we focus on solutions, effective processes and we constantly seek to improve our way of doing things. In response to our demanding environment we offer opportunities to bring forward ideas, lead change as well opportunities for personal development and growth. The company offers competitive terms and conditions.

A propos de nous

Le Groupe Vifor Pharma, anciennement Groupe Galenica, est une entreprise Specialty Pharma mondiale qui se consacre à la recherche, au développement, à la fabrication et à la commercialisation de ses propres produits pharmaceutiques. Il est le partenaire de choix pour les solutions innovantes axées sur le patient. L’entreprise, qui entend devenir le leader mondial des traitements de la carence en fer et des affections néphrologiques et cardio-rénales, aspire à aider les patients du monde entier souffrant de maladies graves et chroniques à mener une vie meilleure et plus saine. Le Groupe Vifor Pharma possède des sites de production en Suisse et au Portugal, ainsi qu’un réseau dynamique de sociétés affiliées et de partenaires lui assurant une vaste couverture de marché dans le monde entier. L’entreprise affiche une présence mondiale en constante augmentation mais conserve de solides racines dans son marché d’origine, la Suisse.

Le Groupe Vifor Pharma est constitué de Vifor Pharma, de Vifor Fresenius Medical Care Renal Pharma – sa société commune avec Fresenius Medical Care –, de Relypsa et d’OM Pharma.

Pour plus d’informations, veuillez consulter notre site: http://www.viforpharma.com/fr/a-propos-de-vifor-pharma/qui-sommes-nous.

Afficher/masquer le contenu

Postuler
Partager
LinkedIn Xing Send to a friend

Conditions pour les agences de placement